Haifeng Song

Haifeng Song


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2009 in Analytical Sciences
Verified
Journal Article
Open access
PDF file
JFJie Fu
Jie Fu
DLDing Li
Ding Li
SXShaoyou Xia
Shaoyou Xia
HSHaifeng Song
Haifeng Song
ZDZengxiang Dong
Zengxiang Dong
ZTZhongming Tang
Zhongming Tang
Real-time quantitative PCR (QPCR) has been proven to be a powerful tool for quantifying specific target DNA sequences. Compared to relative quantification, absolute quantification has the advantage of determining the absolute copy number of a given target, such as pathogen or plasmid DNA in vivo. However, matrix or impurities remaining in a DNA sample after various sample treatment procedures may influence a subsequent DNA analysis. In this work, we have compared methods of sample processing and validated the use of tissue genomic DNA as a universal external standard to facilitate quantification of plasmid DNA in biological matrix, especially addressing the amplification inhibition due to matrix effect and sample complexity. Also, we applied our high-throughput sample preparation and absolute quantification method to determine the distribution of an HIV plasmid DNA vaccine in vivo. Successful application showed the validity and reliability of the method in absolute quantification of a particular gene in vivo.

1 January 2023 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
JZJing Zhang
Jing Zhang
HSHaijing Song
Haijing Song
YDYanan Dong
Yanan Dong
GLGanghui Li
Ganghui Li
JLJun Li
Jun Li
HSHaifeng Song
Haifeng Song
Background: Extracellular vesicles (EVs) are considered a promising drug delivery platform. Naïve EVs face numerous issues that limit their applications, such as fast clearance, hepatic accumulations, and a lack of target-specific tropism. We aimed to explore a series of surface engineering approaches to: 1) reduce the non-specific adhesion of EVs, and 2) improve their enrichment in the target tissue. As a proof-of-concept, we investigated the therapeutic potentials of a multi-modal EVs system carrying a tumor-specific nanobody and the immuno-stimulant interleukin-12 (IL12) using in vivo models of hepatocellular carcinoma. Methods: The major cell adhesion molecule on the HEK293-derived EVs, integrin β 1 (ITGB1), was knocked out (KO) by CRISPR/Cas9-mediated gene editing, followed by deglycosylation to generate ITGB1−Deg EVs for the subsequent pharmacokinetic and biodistribution analyses. ITGB1−Deg EVs were further loaded with glypican-3 (GPC3)-specific nanobody (HN3) and mouse single-chain IL12 (mscIL12) to generate ITGB1−mscIL12+HN3+Deg EVs, for evaluation of tumor tropism and therapeutic potential in a mice model of hepatocellular carcinoma. Results: Removal of ITGB1 led to the broad suppression of integrins on the EVs surface, resulting in a decrease in cellular uptake. Deglycosylation of ITGB1− EVs gave rise to inhibition of the EVs uptake by activated RAW264.7 cells. ITGB1 removal did not significantly alter the pharmacokinetic behaviors of HEK293-EVs, whereas the ITGB1−Deg EVs exhibited enhanced systemic exposure with reduced hepatic accumulation. Loading of HN3 conferred the ITGB1−Deg EVs with tumor-specific tropism for both subcutaneous and metastasized tumors in mice. The ITGB1−mscIL12+HN3+Deg EVs activated mouse splenocytes with high potency. Systemic administration of the EVs with the equivalent dose of 1.5μg/kg of exosomal IL12 achieved satisfactory tumor growth inhibition and good tolerability. Conclusion: The combinatorial approach of EVs surface engineering conferred HEK293-EVs with reduced non-specific clearance and enhanced tumor targeting efficacy, which constituted an efficient delivery platform for critical cancer therapeutics like IL12.

24 January 2022 in Clinical and Translational Medicine
Verified
Journal Article
Open access
PDF file
MXMiaomiao Xue
Miaomiao Xue
SLShuya Li
Shuya Li
MXMingzhi Xu
Mingzhi Xu
LYLi Yan
Li Yan
DLDaniel T. Laskowitz
Daniel T. Laskowitz
YWYi Wang
Yi Wang
Click on the article title to read more.

25 June 2012 in Acta Pharmacologica Sinica
Verified
Journal Article
Open access
HDHai-Yan Du
Hai-Yan Du
LDLi-Hou Dong
Li-Hou Dong
BZBi-Jun Zhao
Bi-Jun Zhao
JFJie Fu
Jie Fu
QWQing-Qing Wang
Qing-Qing Wang
HSHaifeng Song
Haifeng Song
Aim: Methods: Results: Conclusion:

6 February 2020 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
JTJing Tong
Jing Tong
PZPeng Zhang
Peng Zhang
LZLei Zhang
Lei Zhang
DZDongwei Zhang
Dongwei Zhang
DBDavid N. Beratan
David N. Beratan
TLTie Li
Tie Li

2 September 2022 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
MXMingzhi Xu
Mingzhi Xu
GCGang Chen
Gang Chen
YDYanan Dong
Yanan Dong
SXShensi Xiang
Shensi Xiang
MXMiaomiao Xue
Miaomiao Xue
YWYi Wang
Yi Wang
Background: Neural stem cells (NSCs)-derived extracellular vesicles (EVs) possess great potential in treating severe neurological and cerebrovascular diseases, as they carry the modulatory and regenerative ingredients of NSCs. Induced pluripotent stem cells (iPSCs)-derived NSCs culture represents a sustainable source of therapeutic EVs. However, there exist two major challenges in obtaining a scalable culture of NSCs for high-efficiency EVs production: (1) the heterogeneity of iPSC-derived NSCs culture impairs the production of high-quality EVs and (2) the intrinsic propensity of neuronal or astroglial differentiation of NSCs during prolonged culturing reduces the number of NSCs for preparing EVs. A NSCs strain that is amenable to stable self-renewal and proliferation is thus greatly needed for scalable and long-term culture.Methods: Various constructs of the genes encoding the orphan nuclear receptor NR2E1 (TLX) were stably transfected in iPSCs, which were subsequently cultured in a variety of differentiation media for generation of iNSCsTLX. Transcriptomic and biomarker profile of iNSCsTLXwere investigated. In particular, the positivity ratios of Sox2/Nestin and Musashi/Vimentin were used to gauge the homogeneity of the iNSCsTLXculture. The iNSCs expressing a truncated version of TLX (TLX-TP) was expanded for up to 45 passages, after which its neuronal differentiation potential and EV activity were evaluated.Results: Stable expression of TLX-TP could confer the iPSCs with rapid and self-driven differentiation into NSCs through stable passaging up to 225 days. The long-term culture of NSCs maintained the highly homogenous expression of NSC-specific biomarkers and potential of neuronal differentiation. EVs harvested from the TLX-expressing NSCs cultures exhibited anti-inflammatory and neuroprotective activities.Conclusions: iPSC-derived NSCs stably expressing TLX-TP is a promising cell line for scalable production of EVs, which should be further exploited for therapeutic development in neurological treatment.